S. 2531: Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
The Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 aims to improve the early detection and treatment of uterine fibroids, a common health issue among women. Here are the key points of the bill:
Purpose of the Act
The Act authorizes the Secretary of Health and Human Services (HHS) to:
- Conduct or support research focused on enhancing the early detection and intervention of uterine fibroids.
- Develop evidence-based or evidence-informed strategies based on research findings to improve detection in healthcare settings.
Grant Programs
The bill allows the Secretary to award grants to states for several purposes related to uterine fibroids:
- Increase early detection and intervention programs.
- Develop and implement public awareness and educational campaigns regarding uterine fibroids.
Use of Grant Funds
States receiving grants can utilize the funds for various activities aimed at enhancing the early detection and intervention of uterine fibroids, including:
- Screening procedures, which may cover advanced gynecological imaging costs.
- Patient navigation services to assist individuals in accessing healthcare.
- Implementation of the evidence-based strategies developed by HHS.
- Improving access to healthcare settings for screenings and treatments.
Research Focus
The Secretary may also award grants specifically designated for research that includes clinical trials. Areas of research could involve:
- Disparities in pain control and management for those undergoing surgical treatment for uterine fibroids.
- Conditions such as Asherman's Syndrome and other intrauterine adhesions.
Reporting Requirements
The Secretary of HHS must report to Congress on the activities resulting from grants awarded under this Act:
- A summary report of findings and results from funded programs will be submitted within two years of the initial grant awards, and every two years thereafter.
- Include updates on research findings concerning pain management in surgical treatments for uterine fibroids and information regarding related uterine conditions.
Overall Aim
The overall objective of the bill is to enhance the understanding, management, and treatment of uterine fibroids, ultimately aiming to improve women's health outcomes related to this condition.
Relevant Companies
None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
2 bill sponsors
Actions
2 actions
Date | Action |
---|---|
Jul. 30, 2025 | Introduced in Senate |
Jul. 30, 2025 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.